Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Paraneoplastic syndromes

S J Eckhardt1

  • 1Department of Clinical Oncology, National Institute of Oncology, Budapest, Hungary.

Cancer Surveys
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Paraneoplastic syndromes, which accompany cancer, are well-established. Advances in molecular pathology are key to understanding their origins and developing new treatments for cancer patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Future directions: bladder cancer.

Cancer surveys·2004
Same journal

Radiotherapy and chemotherapy for invasive bladder cancer.

Cancer surveys·2004
Same journal

The role of surgery in the multimodality treatment of bladder cancer.

Cancer surveys·2004
Same journal

Clonal development of bladder cancer and its relevance to the clinical potential of HLA antigen and TP53 based gene therapy.

Cancer surveys·2004
Same journal

Clinical evaluation of immunotherapy: are there differences between papillary and flat in situ bladder cancer?

Cancer surveys·2004
Same journal

Molecular biological changes in bladder cancer.

Cancer surveys·2004
See all related articles

Area of Science:

  • Oncology
  • Pathology
  • Molecular Biology

Background:

  • Paraneoplastic syndromes are a diverse group of disorders that occur in cancer patients.
  • Their clinical manifestations have been recognized throughout the history of malignancy.
  • Understanding the underlying mechanisms is crucial for patient care.

Purpose of the Study:

  • To highlight the existence and historical significance of paraneoplastic syndromes.
  • To emphasize the role of molecular pathology in elucidating their origins.
  • To underscore the need for developing novel therapeutic strategies.

Main Methods:

  • Review of historical and current literature on paraneoplastic syndromes.
  • Discussion of the potential contributions of molecular pathology.

Related Experiment Videos

  • Exploration of therapeutic challenges and opportunities.

    • Main Results:

    • Paraneoplastic syndromes are a recognized clinical entity with a long history.
    • Molecular pathology offers promising avenues for understanding the pathogenesis of these syndromes.
    • Effective therapeutic interventions are needed to manage associated patient disorders.

    Conclusions:

    • The existence of paraneoplastic syndromes is undeniable.
    • Progress in molecular pathology is essential for unraveling their etiology.
    • Developing effective treatments is a critical obligation for improving cancer patient outcomes.